Age-Related Macular Degeneration Market Driven by Technological Advancements in Imaging & Therapies | F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Novartis AG, Apellis Pharmaceuticals, Inc.

The Age Related Macular Degeneration market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment opportunities, product development strategies, or expansion into high-growth regions, this report serves as your essential guide to navigating today's dynamic market environment.

Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/age-related-macular-degeneration-market?ophp

Age Related Macular Degeneration Market Growth

Age-Related Macular Degeneration Market reached US$ 15.43 billion in 2024 and is expected to reach US$ 26.58 billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.

Comprehensive Insight into Age Related Macular Degeneration Market Landscape and Growth Trends:

Age-Related Macular Degeneration (AMD) is a progressive eye disorder that affects the macula, causing vision loss in older adults. The market is gaining momentum as aging populations rise, driving demand for advanced retinal treatments and innovative therapies targeting wet and dry AMD.

Major Players Shaping the Competitive Landscape:

F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Novartis AG, Apellis Pharmaceuticals, Inc., Astellas Pharma Inc., Biocon, Samsung Bioepis, Bausch + Lomb, Alcon Inc., and Nature Made, among others.

Important Mergers, Acquisitions, and Market Shifts:

✅ On June 24, 2025, researchers from Washington University discovered that correcting cholesterol metabolism in retinal cells may slow or prevent AMD progression in mice-potentially linking AMD with cardiovascular health

✅ In June 2025 JAMA Ophthalmology study linked GLP-1 medications (e.g., Ozempic, Wegovy) to a doubling in wet AMD risk among older adults with diabetes. Although the absolute risk remains low, experts recommend monitoring vision closely
✅ In May 2025, NIH researchers debuted a new surgical method in animal studies to implant multiple tissue grafts into the retina-advancing prospects for cell-based therapy in dry AMD

✅ At ARVO 2025 in May, the LIGHTSITE III trial demonstrated photobiomodulation therapy led to an average 5.6-letter vision improvement at 24 months and reduced geographic atrophy risk in dry AMD, marking a milestone in non-drug treatment options

✅ On March 22, 2025, Kalaris Therapeutics completed its merger with AlloVir, securing $100 million to develop TH103-a long-acting anti-VEGF candidate targeting neovascular AMD, with Phase 1 data expected in late 2025

✅ In January 2025, the UK's MHRA rejected Apellis's Syfovre (pegcetacoplan)-a complement inhibitor for geographic atrophy-highlighting ongoing regulatory challenges in late-stage dry AMD treatment approval

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/age-related-macular-degeneration-market?ophp

Methodology and Scope:

This Age Related Macular Degeneration Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Age Related Macular Degeneration Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Age Related Macular Degeneration market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Age Related Macular Degeneration industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Age Related Macular Degeneration market?

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=age-related-macular-degeneration-market?ophp

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.